Treg cells in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus patients

References

• Veyradier A, Meyer D. Thrombotic thrombocytopenic purpura and its diagnosis. J Thromb Hemost. 2005;3:2420–2427
   Google Scholar
• Sadler JE, Moake JL, Miyata T, George JN. Recent advances in thrombotic thrombocytopenic purpura. Hemat Am Soc Hematol Educ Program. 2004;3:407–423. doi:10.1182/asheducation-2004.1.407
   Google Scholar
• Letchumanan P, Ng HJ, Lee LH, Thumboo J. A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus. Rheumatology (Oxford). 2009;48:399–403
   PubMed Web of Science ®Google Scholar
• Musio F, Bohen EM, Yuan CM, Welch PG. Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum. 1998;28:1–19
   PubMed Web of Science ®Google Scholar
• Zheng T, Chunlei L, Zhen W, et al. Clinical-pathological features and prognosis of thrombotic thrombocytopenic purpura in patients with lupus nephritis. Am J Med Sci. 2009;338:343–347
   Google Scholar
• Lansigan F, Isufi I, Tagoe CE. Microangiopathic hemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: The role of ADAMTS13. Rheumatology (Oxford). 2011;50:824–829
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531–562
   PubMed Web of Science ®Google Scholar
• Shevach EM, McHugh RS, Piccirillo CA, Thornton AM. Control of T-cell activation by suppressor T cells. Immunol Rev. 2001;182:58–67
   PubMed Web of Science ®Google Scholar
• Powrie F, Read S, Mottet C, Uhlig H, Maloy K. Control of immune pathology by regulatory T cells. Novartis Found Symp. 2003;252:92–98 (discussion 2003;98–105:106–114)
   PubMedGoogle Scholar
• Shi H-Z, Qin X-J. D4+CD25+ regulatory T lymphocytes in allergy and asthma. Allergy. 2005;60:986–995
   PubMed Web of Science ®Google Scholar
• Desch KC, Motto DG. Thrombotic thrombocytopenic purpura in humans and mice. Arterioscler Thromb Vasc Biol. 2007;27:1901–1908
   Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Yagi H, Ishizashi H, Wada H, Fujimura Y. The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Semin Hematol. 2004;41:68–74
   PubMed Web of Science ®Google Scholar
• De Cristofaro R, Peyvandi F, Palla R, et al. Role of chloride ions in modulation of the interaction between von Willebr and factor and ADAMTS-13. J Biol Chem. 2005;280:23295–23302
   PubMed Web of Science ®Google Scholar
• Jiang L, Liu G, Lv J, et al. Concise semiquantitative histological scoring system for immunoglobulin A nephropathy. Nephrology (Carlton). 2009;14:597–605
   Google Scholar
• Haas M. Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29:829–842
   PubMed Web of Science ®Google Scholar
• Franchini M, Zaffanello M, Veneri D. Advances in the pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Thromb Res. 2006;118:177–184
   PubMed Web of Science ®Google Scholar
• Lowe E, Werner E. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in children and adolescents. Semin Thromb Hemost. 2005;31:717–730
   Google Scholar
• Zakarija A, Bennett C. Drug-induced thrombotic microangiopathy. Semin Thromb Hemost. 2005;31:681–690
   PubMed Web of Science ®Google Scholar
• Mottet C, Uhlig HH, Powrie F. Cutting edge: Cure of colitis by CD4+CD25+ regulatory T cells. J Immunol. 2003;170:3939–3943
   PubMed Web of Science ®Google Scholar
• Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med. 1999;190:995–1004
   PubMed Web of Science ®Google Scholar
• Thornton AM, Shevach EM. Suppressor effector function of immunoregulatory T cells is antigen nonspecific. J Immunol. 2000;164:183–190
   PubMed Web of Science ®Google Scholar
• Huang H, Peng Y, Liu F, Lei H. Is IgA nephropathy induced by abnormalities of Treg cells in the tonsils? Med Hypotheses. 2007;69:410–413
   Google Scholar
• Akbari O, Freeman GJ, Meyer EH, et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med. 2002;8:1024–1032
   PubMed Web of Science ®Google Scholar
• McGuirk P, McCann C, Mills KH. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: A novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med. 2002;195:221–231
   PubMed Web of Science ®Google Scholar
• Boumpas DT, Fessler BJ, Austin HA, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: Emerging concepts. Ann Intern Med. 1995;123:42–53
   Google Scholar
• D’Cruz DP, Houssiau FA, Ramirez G, et al. Antibodies to endothelial cells is sytemic lupus erythematosus: A potential marker for nephritis and vasculitis. Clin Exp Immunol. 1991;85:254–261
   PubMedGoogle Scholar
• Perry GJ, Elston T, Khouri NA, Chan TM, Cameron JS, Frampton G. Antiendothelial cell antibodies in lupus: Correlations with renal injury and circulating markers of endothelial damage. Q J Med. 1993;86:727–734
   PubMedGoogle Scholar
• Chu R, Russell NH, Powell RJ, Cater DR, Harris RJ. Abnormal fibrinolytic activity in systemic lupus erythematosus and possible mechanisms. Br J Rheumatol. 1988;27:436–439
   Google Scholar
• Awada H, Barlowatz-Meimon G, Dougados M, Maisonneuve P, Sultan Y, Amor B. Fibrinolysis abnormalities in systemic lupus erythematosus and their relation to vasculitis. J Lab Clin Med. 1988;111(2):229–236
   Google Scholar